Real-time enrollment status for this lupus nephritis (ln) clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:29 AM UTC
| NCT Number | NCT06975787 |
| Recruiting Status | Recruiting |
| Condition | Lupus Nephritis (LN) |
| Phase | PHASE1 |
| Target Enrollment | 90 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 16, 2026: Clinical trial NCT06975787 is currently recruiting participants. This phase1 study for lupus nephritis (ln) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06975787 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06975787 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.